Probi AB (publ) takes over all distribution of BLIS K12 and BLIS M18 in the US and Canada after Blis Technologies distribution agreement with its previous partner ends. Since 2021, Probi has a partnership for the dairy-free production and distribution of Blis' products. The technology transfer of the manufacturing has been completed, and Probi will be the sole distributor of bulk products for BLIS K12 and BLIS M18 on the North American market.

Since July 2021, Probi and Blis Technologies have a long-term strategic partnership for the distribution and manufacture of BLIS probiotic strains in oral health. Blis Technologies has now ended the distribution agreement with a previous partner, which means that as of August 1, 2023, Probi will be the sole distributors of BLIS K12 and BLIS M18 ingredients in the USA and Canada. Probi has also completed the technology transfer for the production of dairy-free BLIS K 12 and BLIS M 18 in their manufacturing facility in Redmond, Washington, which means that Probi has full-scale production capacity of both bulk powder and product applications of the strains.